Cell Biology

Focal Adhesions

Integrin-anchored signaling hubs that connect the actin cytoskeleton to the ECM

Focal adhesions are integrin-anchored signaling hubs that physically tether the actin cytoskeleton to the extracellular matrix. Each adhesion contains roughly 150 distinct proteins layered into nanoscale strata — integrins on the membrane, talin and kindlin in the force-transduction layer 30 nm above, vinculin and FAK in the signaling layer, and contractile actin bundles 50 to 60 nm above the membrane. Mature adhesions are 1 to 5 µm long with lifetimes of 5 to 30 minutes. They are the cell's mechanosensors — translating substrate stiffness into biochemistry that drives differentiation, migration, and survival.

  • Proteins per adhesion~150 distinct components
  • Adhesion lifetime5–30 min (focal); ~1 min (nascent)
  • Talin force range5–25 pN unfolds the rod
  • Layered structure3 strata, 10/30/50 nm above membrane
  • DiscoveredAbercrombie 1971; nano-arch Kanchanawong 2010
  • Integrin diseaseGlanzmann thrombasthenia (αIIbβ3)

Interactive visualization

Press play, or step through manually. The visualization is yours to drive — try it before reading on.

Open visualization fullscreen ↗

Watch the 60-second explainer

A condensed visual walkthrough — narrated, captioned, under a minute.

Why focal adhesions matter

  • The cell's mechanical sensor. Focal adhesions translate substrate stiffness into intracellular signaling. Mesenchymal stem cells on 1 kPa gels (brain-soft) become neurons; on 10 kPa (muscle-stiff) become myocytes; on 30 kPa (bone-stiff) become osteoblasts. The Engler, Sen, Discher 2006 Cell paper made this stiffness-driven differentiation a foundational result of mechanobiology — and the readout happens at the talin-vinculin layer of the adhesion.
  • Required for cell migration. A migrating fibroblast assembles new adhesions at the leading-edge lamellipodium and disassembles them at the rear. The cycle takes 10 to 30 minutes per adhesion. Without functional integrins or talin, cells cannot generate traction; without disassembly, they cannot release the rear and move forward.
  • FAK signaling is essential for embryogenesis. FAK knockout mice die at E8.5 with mesodermal defects. The kinase autophosphorylates at Y397 upon integrin clustering, recruits Src, and propagates signals through Ras-MAPK (proliferation), PI3K-AKT (survival), and Rac-Cdc42 (migration). FAK inhibitors like defactinib (VS-6063) are in clinical trials for mesothelioma, ovarian, and pancreatic cancer.
  • Drug targets for thrombosis and cancer. Abciximab (ReoPro), the first FDA-approved monoclonal antibody, blocks platelet integrin αIIbβ3 and reduces ischemic events after coronary intervention. Tirofiban and eptifibatide are small-molecule αIIbβ3 antagonists in the same class. Cilengitide targeted αvβ3/αvβ5 in glioblastoma trials but failed phase III — a cautionary tale for integrin pharmacology.
  • Adhesion stiffness sensing drives cancer progression. Tumor stroma stiffens up to 10x as collagen crosslinks accumulate. The stiff matrix activates focal-adhesion mechanotransduction in cancer cells, driving YAP/TAZ nuclear translocation, proliferation, and metastatic invasion. Lysyl oxidase inhibitors that prevent stromal stiffening are in oncology development.
  • Fibrillar adhesions assemble fibronectin. Centrally located, elongated tensin-rich fibrillar adhesions translocate α5β1 integrin away from the leading edge along stress fibers, dragging fibronectin dimers and triggering them to unfold and polymerize into the fibrillar matrix that organizes the ECM. Without this, basement membranes fail to mature.
  • Conserved across all metazoans. Sponges, jellyfish, flies, fish, and humans all use integrin-talin-vinculin-FAK adhesions with the same layered architecture. The core machinery predates the bilaterian split. Plants and fungi have independently evolved different ECM-attachment strategies because they lack integrins.

Common misconceptions

  • All adhesions are focal adhesions. No — there is a developmental progression: nascent adhesions (~100 nm, <1 min, no actin connection), focal complexes (~1 µm, 1 to 10 min, lamellipodium/lamellum boundary), focal adhesions (1 to 5 µm, 5 to 30 min, anchor stress fibers), and fibrillar adhesions (elongated, central, organize fibronectin matrix). Each has distinct composition and dynamics.
  • Integrins are always active. Integrins exist in three conformations: bent-closed (low affinity for ECM), extended-closed (intermediate), and extended-open (high affinity). Talin and kindlin binding to the β tail induces extension; ECM ligand binding stabilizes the open state. This bidirectional activation — inside-out and outside-in — is essential for regulated adhesion. Constitutively active integrins cause platelet hyperactivation and clotting.
  • Focal adhesions are static. They are dynamic protein assemblies in continuous turnover. FRAP measurements show that even "mature" focal adhesions exchange their core components (vinculin, talin, paxillin) on timescales of seconds to minutes. The structure persists; the molecules cycle.
  • Vinculin glues actin to talin. Vinculin is autoinhibited in the cytosol — its head and tail bind each other. Recruitment to talin's force-exposed binding sites separates head from tail and activates vinculin. Only then can it bind both talin (head) and actin (tail), serving as a force-induced molecular clutch. Static glue would not provide stiffness sensing.
  • Higher force always means stronger adhesion. The catch-bond behavior of integrins means binding lifetime increases with force up to a peak, then decreases. Beyond ~30 to 50 pN per integrin–ligand pair, bonds rapidly break. Adhesions sustain large forces only by sharing load across many integrins (clustering).
  • Adhesions form on any surface. Integrins recognize specific ligand motifs — the RGD tripeptide in fibronectin and vitronectin, GFOGER in collagen, LDV in fibronectin's CS-1, and so on. Polyethylene glycol surfaces are non-adhesive precisely because they lack integrin binding sites; cells round up and die (anoikis) if forced to remain.

How focal adhesions work

Adhesion biogenesis begins when a leading-edge protrusion contacts the ECM. Bent-closed integrin heterodimers (an α and a β chain together — humans have 18 α and 8 β subunits combining into 24 known αβ pairs) cluster underneath the membrane. Talin in the cytosol is autoinhibited (the FERM head buries the rod's vinculin-binding sites). PI(4,5)P2 enrichment at the membrane and Rap1-RIAM signaling break talin autoinhibition; the FERM head binds the integrin β cytoplasmic tail and induces extension — this is inside-out activation. The extended integrin then engages an ECM ligand (e.g., the RGD motif of fibronectin), completing outside-in activation. Kindlin co-binds the β tail at a distinct site and is also required for stable activation. Roughly 50 to 100 integrin–talin pairs cluster within ~100 nm to form a nascent adhesion.

The nanoscale architecture is stratified, not a soup. Pakorn Kanchanawong and Clare Waterman's 2010 super-resolution iPALM imaging of mouse embryonic fibroblasts revealed three vertical layers above the inner plasma membrane. The integrin signaling layer at ~10 nm contains paxillin and FAK, anchored to the integrin cytoplasmic tails. The force-transduction layer at ~30 nm is dominated by talin (oriented as an elongated rod, head-down) and kindlin. The actin-regulatory layer at ~50 to 60 nm holds vinculin, VASP, α-actinin, and zyxin, where contractile stress fibers attach. Talin's rod spans roughly the height between the integrin and actin layers and acts as the structural and mechanical bridge.

Mechanotransduction happens in the talin rod. Actomyosin contractility (myosin II generating ~5 pN per motor head, summed over many filaments) pulls on the actin layer; that load is transmitted through vinculin into the talin rod and out to the integrin. Force unfolds the helical bundles of talin one at a time, exposing eleven cryptic vinculin-binding sites. Vinculin binding both reinforces the connection (more actin attachment) and recruits more talin in a positive feedback. On stiff substrates the rod unfolds to high extents and the adhesion matures; on soft substrates the rod remains folded, vinculin doesn't bind, and the adhesion fails to mature and disassembles. The transcriptional readout converges on YAP/TAZ — co-activators retained in the cytosol when adhesions are weak, and translocated to the nucleus when adhesions mature, driving proliferation and survival programs.

Nascent vs focal complex vs focal adhesion vs fibrillar

PropertyNascentFocal complexFocal adhesionFibrillar
Size~100 nm~1 µm round1–5 µm elongated5–10 µm thin streaks
Lifetime<1 min (~80% turn over)1–10 min5–30 min, sometimes hourstens of minutes to hours
LocationBehind lamellipodiumLamellipodium–lamellum boundaryEnd of stress fiber, cell bodyCentral, away from edge
Actin attachmentNoneFormingAnchors stress fiberLinked, sliding
Key componentsIntegrin, paxillin, FAK+ α-actinin, some vinculin+ Vinculin, talin, zyxin+ Tensin, α5β1 prominent
Force loadingLow (actin not engaged)IncreasingHigh (myosin II contracts)Translocating, lower than FA
Dependence on Rho-ROCKIndependentPartialRequired (Y-27632 collapses)Required for translocation
FunctionInitial probeTest tractionSustained adhesion + signalingFibronectin matrix assembly

Integrin αβ pairs and their ligands

IntegrinMain ligandCell typeDisease association
α5β1Fibronectin (RGD)Fibroblasts, most cellsTumor angiogenesis target
αvβ3Vitronectin, fibrinogen, RGDEndothelium, osteoclasts, tumorTumor angiogenesis (cilengitide)
αIIbβ3FibrinogenPlatelets onlyGlanzmann thrombasthenia (loss); thrombosis (gain)
α6β4Laminin-332Basal keratinocytes (hemidesmosomes)Epidermolysis bullosa pluriforme
αLβ2 (LFA-1)ICAM-1, ICAM-2LeukocytesLAD type I (β2/CD18 mutations)
αMβ2 (Mac-1)iC3b, fibrinogenMacrophages, neutrophilsLAD type I
α2β1Collagen (GFOGER)Platelets, epitheliumBleeding disorders (rare)
α4β7MAdCAM-1Gut-homing lymphocytesIBD target (vedolizumab)

Famous experiments

  • Abercrombie's interference reflection microscopy (1971). Michael Abercrombie used IRM at UCL to visualize the close contacts (later named focal adhesions) on the underside of crawling chick fibroblasts. The dark patches in IRM corresponded to membrane regions within ~10 nm of the substrate — the first evidence of discrete attachment sites rather than continuous adhesion.
  • Kanchanawong & Waterman iPALM nanoscale architecture (2010). Using interferometric photoactivated localization microscopy on mouse embryonic fibroblasts, Pakorn Kanchanawong, Clare Waterman, and colleagues at NIH resolved focal adhesions into three distinct vertical layers spanning ~40 nm. Published in Nature 468: 580–584; redefined adhesions as architecturally precise nanostructures.
  • Engler, Sen, Discher stiffness-driven differentiation (2006). Plating mesenchymal stem cells on polyacrylamide hydrogels of tunable stiffness, the Discher lab at Penn showed differentiation tracks substrate stiffness alone — neurons on 1 kPa, myocytes on 10 kPa, osteoblasts on 30 kPa — with no chemical induction. Cell 126: 677–689; foundational paper of mechanobiology.
  • Talin-vinculin force unfolding (Yan & Sheetz labs, 2014). Single-molecule magnetic tweezers stretched individual talin rods and recorded force-induced unfolding of the helical bundles between 5 and 25 pN, with vinculin binding to the unfolded states. The experiment directly demonstrated talin as a tunable mechanical switch — the molecular basis of stiffness sensing.
  • FAK knockout (Ilic et al., 1995). Generated FAK-null mouse embryos that died at E8.5 with mesodermal defects and disorganized somites. FAK-null fibroblasts showed enlarged, more numerous focal adhesions and reduced migration speed — paradoxical at first, but explained by the role of FAK in adhesion turnover, not formation.

Frequently asked questions

What is the architecture of a focal adhesion?

Super-resolution imaging by Pakorn Kanchanawong and Clare Waterman (2010, Nature) revealed focal adhesions as stratified nanoscale layers between the plasma membrane and the actin stress fiber. The basal layer (~10 nm above the inner membrane) contains the cytoplasmic tails of integrin αβ heterodimers and is rich in paxillin and focal adhesion kinase (FAK) — the integrin signaling layer. Above that, a force-transduction layer at ~30 nm contains talin's elongated rod and kindlin. The actin-regulatory layer at ~50 to 60 nm holds vinculin, VASP, α-actinin, and zyxin, anchoring contractile actin bundles. Each mature focal adhesion contains an estimated 150 distinct proteins assembled in a precise vertical organization.

How does talin act as a mechanosensor?

Talin is a 270-kDa protein with an N-terminal FERM head that binds and activates integrin β tails, and a C-terminal rod composed of 13 helical bundles. The rod is the mechanical element. Force applied through actomyosin contractility (typically 5 to 25 pN per molecule) progressively unfolds talin's helical bundles, exposing cryptic vinculin-binding sites — eleven of them across the rod. Vinculin recruitment in turn binds more actin and recruits more talin, producing a force-amplifying positive feedback. Below ~5 pN per molecule, talin remains folded and adhesions disassemble. The talin rod is therefore a tunable mechanical switch — the molecular basis for stiffness sensing across cell types from stem cells to neurons.

What does FAK do?

Focal adhesion kinase (PTK2/FAK) is a non-receptor tyrosine kinase recruited to nascent adhesions by binding paxillin and integrin tails. Integrin clustering induces FAK autophosphorylation at Y397, which creates a high-affinity binding site for Src kinase. Src then phosphorylates additional FAK residues (Y576, Y577, Y861, Y925), creating docking sites for Grb2-SOS (Ras-MAPK signaling), PI3K (AKT survival signaling), and p130Cas (Rac/lamellipodial dynamics). FAK knockout mouse embryos die at E8.5 with mesodermal defects. FAK inhibitors like defactinib are in clinical trials for solid tumors, since cancer cells often depend on FAK-driven survival and migration signals.

What are the stages of focal adhesion maturation?

Adhesions form at the leading edge of a migrating cell in three stages. Nascent adhesions (~100 nm, ≤1 minute lifetime) form behind the lamellipodium and contain integrins, paxillin, and FAK but no actin connection. Roughly 80% disassemble; the rest mature. Focal complexes (~1 µm, 1 to 10 minute lifetime) sit at the lamellipodium-lamellum junction and recruit α-actinin and vinculin as actomyosin contractility engages. Focal adhesions (1 to 5 µm, 5 to 30 minute lifetime, sometimes hours) anchor stress fibers in the cell body. Fibrillar adhesions, found centrally, are elongated structures rich in tensin that organize fibronectin matrix assembly. Stage transitions are driven by Rho-ROCK-myosin contractility — relax it (e.g., with Y-27632) and adhesions shrink to nascent complexes.

How do cells sense substrate stiffness through focal adhesions?

Stiffness sensing happens at the talin–vinculin axis. On a stiff substrate (e.g., bone matrix at ~100 kPa or harder), actomyosin contractility loads talin to high force, talin rod unfolds, vinculin binds, adhesions reinforce, and stress fibers stabilize. On a soft substrate (e.g., brain at ~1 kPa), substrate compliance dissipates contractile force, talin remains folded, vinculin doesn't bind, and adhesions disassemble. The cell reads this as a stiffness signal. Engler, Sen, and Discher (2006, Cell) showed that mesenchymal stem cells differentiate to neurons on 0.1 to 1 kPa hydrogels, myocytes on 8 to 17 kPa, and osteoblasts on 25 to 40 kPa — pure stiffness, no chemical cue. This is the foundational result of mechanobiology.

What human diseases involve integrin or focal-adhesion mutations?

Glanzmann thrombasthenia: αIIbβ3 integrin mutations on platelets cause life-threatening bleeding because platelets cannot bind fibrinogen and aggregate. Leukocyte adhesion deficiency type I: β2 integrin (CD18) mutations prevent leukocytes from arresting on inflamed endothelium, producing recurrent bacterial infections. Kindler syndrome: KIND1 (kindlin-1) mutations produce skin blistering and photosensitivity because basal keratinocytes cannot form stable focal adhesions to laminin-332. Epidermolysis bullosa pluriforme: α6β4 integrin mutations cause severe skin fragility. Cancer: integrin α5β1 and αvβ3 are upregulated on tumor cells and tumor vasculature; integrin antagonists (cilengitide, etaracizumab) have been tested in glioblastoma and melanoma trials with mixed results.